Antidepressants as an often overlooked therapeutic option for the treatment and management of arthritis pain: Comment on the article by Wolfe and Michaud

Arthritis Care and Research

Volumn 62, Issue 6, 2010, Pages 901-902

  Kapoor, Shailendra ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DULOXETINE; MILNACIPRAN;

ANALGESIA; ANALGESIC ACTIVITY; ARTHRITIS PAIN; DEPRESSION; DRUG EFFICACY; FIBROMYALGIA; HUMAN; KNEE OSTEOARTHRITIS; LETTER; LOW BACK PAIN; PAIN; RHEUMATOID ARTHRITIS;

ANTIDEPRESSIVE AGENTS; ARTHRITIS, RHEUMATOID; DISEASE MANAGEMENT; HUMANS; PAIN;

EID: 77953097826     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20120     Document Type: Letter

References (5)

1. Wolfe F, Michaud K. Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity. Arthritis Rheum 2009;61:667-73.
2. Barclay L. Depression, musculoskeletal pain may respond to antidepressant therapy, pain self-management. JAMA 2009; 301:2099-110.
3. Chappell AS, Ossanna MJ, Liu-Seifert H, Iyengar S, Skljarevski V, Li LC, et al. Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain 2009;146:253-60.
4. Kroenke K, Bair MJ, Damush TM, Wu J, Hoke S, Sutherland J, et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 2009;301: 2099-110.
5. Branco JC, Zachrisson O, Perrot S, Mainguy Y, and the Multinational Coordinator Study Group. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in the treatment of fibromyalgia. J Rheumatol 2010;37:851-9.